📰 Sera Prognostics News
Page 6 - Sera Prognostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sera Prognostics. Real-time updates on events, politics, business and more.
April 27, 2023
/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...
April 18, 2023
GeneLink (OTCMKTS:GNLKQ – Get Rating) and Sera Prognostics (NASDAQ:SERA – Get Rating) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability and analyst recommendations. Risk and Volatility GeneLink has a beta of 0.06, suggesting that […]
April 16, 2023
Sera Prognostics, Inc. (NASDAQ:SERA – Get Rating) saw a large decline in short interest in March. As of March 31st, there was short interest totalling 242,600 shares, a decline of 23.3% from the March 15th total of 316,100 shares. Based on an average trading volume of 1,310,000 shares, the days-to-cover ratio is currently 0.2 days. […]
April 2, 2023
Sera Prognostics, Inc. (NASDAQ:SERA – Get Rating) was the target of a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 316,100 shares, a decrease of 19.9% from the February 28th total of 394,700 shares. Currently, 2.1% of the shares of the company are sold […]
April 1, 2023
Sera Prognostics, Inc. (NASDAQ:SERA – Get Rating) was the target of a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 316,100 shares, a decrease of 19.9% from the February 28th total of 394,700 shares. Currently, 2.1% of the company’s shares are short sold. Based […]
March 27, 2023
Operator: Good afternoon, and welcome to the Sera Prognostics Conference Call to Review Fourth Quarter and Fiscal Year 2022 results. At this time, all participants are in listen-only mode.
February 15, 2023
FinancialContent fully hosted finance channel
February 15, 2023
/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...
December 22, 2022
Preterm Birth Diagnostic Test Kits Market is anticipated to expand at a CAGR of 7.6% from 2022-2028 and will reach U.S. $ 203.2 Mn by 2028
December 20, 2022
The market for Preeclampsia Therapeutics is anticipated to expand at a CAGR of 7.2% until the year 2032.Preeclampsia refers to a condition in which a pregnant woman develops hypertension during or after giving birth.Access the sample report: https://www.insightslice.com/request-sample/704The key players of the Globa...